Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or no or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
6-chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one
EC Number:
219-163-6
EC Name:
6-chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one
Cas Number:
2379-74-0
Molecular formula:
C18H10Cl2O2S2
IUPAC Name:
6-chloro-2-[(2E)-6-chloro-4-methyl-3-oxo-2,3-dihydro-1-benzothiophen-2-ylidene]-4-methyl-2,3-dihydro-1-benzothiophen-3-one
Test material form:
solid: nanoform

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
-strain: CBA/CaOlaHsd
- Source: Harlan Netherlands
- Age at study initiation: 8-12 weeks (beginning of treatment)
- Weight at study initiation: 19.8 g to 23.3 g
- Housing: single caging, Makrolon Type I, with wire mesh top, granulated soft wood bedding
- Diet (e.g. ad libitum): pelleted standard diet, ad libitum (Harlan Winkelmann GmbH)
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: yes; at least 5 days prior to the start of dosing

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30 - 70 %
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): artificial light 6.00 a.m. - 6.00 p.m.

Study design: in vivo (LLNA)

Vehicle:
dimethyl sulphoxide
Remarks:
VWR International GmbH, purity 99.5 %
Concentration:
0 (control), 5, 10 and 20 % (w/w)
No. of animals per dose:
4 animals per treatment group, 4 animals in the control group
Details on study design:
RANGE FINDING TESTS:
- Compound solubility:
A solubility experiment was performed. The highest test item concentration, which can be technically used was a 20 % (w/w) suspension in DMSO.

In two non GLP studies different batches of the test item were tested and regarded as non sensitizing at concentrations of 20 % respectively. Therefore, a pre-experiment was not performed in the GLP-study.


MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Pooled (4 animals/group) LLNA

- Criteria used to consider a positive response:

A test item is regarded as a sensitiser in the LLNA if the following criteria are fulfilled:

- First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index.
- Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.


TREATMENT PREPARATION AND ADMINISTRATION:
Four female mice were treated with different concentrations of the test item and vehicle alone by topical application at the dorsum of each ear lobe (left and right) on three consecutive days. The application volume, 25 µL, was spread over the entire dorsal surface respectively. Five days after the first topical application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Five hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
mean values and standard deviations of the body weight were calculated

Results and discussion

Positive control results:
Stimulation indices of 5.24, 7.38 and 9.32 were determined in a separate test with the positive control substance at concentrations of 5 %, 10 % and 25 % (w/v), respectively, in acetone:olive oil. The EC3 value was estimated to be < 5%. A precise calculation of the EC3 value was not possible since the S.I. was above the threshold of 3 even at the lowest tested concentration.

In vivo (LLNA)

Resultsopen allclose all
Key result
Parameter:
SI
Value:
1.52
Test group / Remarks:
20%
Remarks on result:
other: The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
Key result
Parameter:
SI
Value:
1.59
Test group / Remarks:
10%
Remarks on result:
other: The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
Key result
Parameter:
SI
Value:
1
Test group / Remarks:
5%
Remarks on result:
other: The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
Key result
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: DPM measured: Control Group: 3462 5 %: 3463 10 %: 5469 20 %: 5237

Any other information on results incl. tables

No deaths occurred during the study period.

Due to the intense red colour of the test item local irritation reactions such as ear redness could not be examined. However, no swelling of the ears was observed.

The body weights of the animals, recorded prior to the first application and prior to necropsy, were within the range commonly recorded for animals of this strain and age.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
regulation (EC) 12727/2008
Conclusions:
The test item (Pigment Red 181) was found to be not a skin sensitiser in the LLNA when tested at concentrations up to 20.0 % in DMSO (w/w).
Executive summary:

In the study the test item suspended in DMSO (w/w) was assessed for its possible contact allergenic potential. For this purpose a local lymph node assay was performed according to OECD TG 429 using test item concentrations of 5, 10 and 20 %. The animals did not show any clinical signs during the course of the study and no cases of mortality were observed. In this study Stimulation indices (S.I.) of 1.00, 1.59, and 1.52 were determined with the test item at concentrations of 5, 10 and 20 % (w/w) in DMSO. The test item was found to be not a skin sensitiser in this assay.